Obesity Medicare - Search News

Medicare should cover Wegovy — but not negotiate its price

Former Trump health official: Medicare should cover Wegovy — but not negotiate its price

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 weight-loss drugs — but says subjecting Wegovy to price controls is a bad move.

Ozempic, Wegovy among drugs selected for Medicare's price negotiations

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.

The New York Times · 2d

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

6don MSN

Patient groups call on Trump administration to let Medicare cover obesity drugs

A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal ...

10don MSN

Eli Lilly's obesity drug gets Medicare coverage for sleep apnea

Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results